BFM
GCTK icon

Boothbay Fund Management’s GlucoTrack GCTK Stock Holding History

Boothbay Fund Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Hold
902
– – ﹤0.01% 2197
2026
Q1 		$8.79K Hold
902
– – ﹤0.01% 1999
2025
Q4 		$52.3K Buy
+902
New +$80.3K ﹤0.01% 1817

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Boothbay Fund Management's GCTK Position: Q2 2026 in Review

Boothbay Fund Management held its GlucoTrack (GCTK) position steady in Q2 2026 at 902 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Boothbay Fund Management first reported a position in GCTK in Q4 2025 and has held it in 3 quarters since. The position peaked at $52.3K in Q4 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Boothbay Fund Management held 902 shares of GlucoTrack worth $4.31K as of Q2 2026.
  • Boothbay Fund Management left its GlucoTrack share count unchanged in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2197 holding.
  • Boothbay Fund Management first reported a position in GlucoTrack in Q4 2025 and has held it in 3 quarters since.
  • Boothbay Fund Management's GlucoTrack position peaked at $52.3K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.